Combined inhalational and oral supplementation of ascorbic acid may prevent influenza pandemic emergency: A hypothesis

Nutrition

Volumn 26, Issue 1, 2010, Pages 128-132

  Banerjee, Dibyajyoti ^a   Kaul, Deepak ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Ascorbic acid; Flu; Influenza; Pandemic; Vitamin C

Indexed keywords

ASCORBIC ACID; DEHYDROASCORBIC ACID;

ANTIVIRAL ACTIVITY; CLINICAL TRIAL; COMMON COLD; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; EMERGENCY CARE; HUMAN; HYPOTHESIS; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS; LABORATORY TEST; LOW DRUG DOSE; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; ASCORBIC ACID; COMMON COLD; DIETARY SUPPLEMENTS; DISEASE OUTBREAKS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN;

ORTHOMYXOVIRIDAE;

EID: 71549147526     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.09.015     Document Type: Review

References (64)

1. Gwaltney Jr. J.M. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases. 4th ed. The common cold Volume 1 (1995), Churchill Livingstone, London, UK 561-566
2. Centers for Disease Control and Prevention. Seasonal influenza (flu). Available at: http://www.cdc.gov/flu/. Accessed June 30, 2009.
3. Douglas R.G.J. Pathogenesis of rhinovirus common colds in human volunteers. Ann Otol Rhinol Laryngol 79 (1970) 563-571
4. Abraham G., and Colonno R.J. Many rhinovirus serotypes share the same cellular receptor. J Virol 51 (1984) 340-345
5. Zambon M.C. The pathogenesis of influenza in humans. Rev Med Virol 11 (2001) 227-241
6. Mossad S.B. The resurgence of swine-origin influenza A (H1N1). Cleveland Clinic Journal of Medicine 76 (2009) 337-343
7. Thomas J.K., and Noppenberger J. Avian influenza: a review. Am J Health Syst Pharm 64 (2007) 149-165
8. García-García J., and Ramos C. Influenza, an existing public health problem. Salud Publica Mex 48 (2006) 244-267
9. Fleming D.M., Elliot A.J., Meijer A., and Paget W.J. Influenza virus resistance to oseltamivir: what are the implications?. Eur J Public Health 19 (2009) 238-239
10. Hemilä H. Vitamin C supplementation and the common cold-was Linus Pauling right or wrong?. Int J Vitam Nutr Res 67 (1997) 329-335
11. Gorton H.C., and Jarvis K. The effectiveness of vitamin C in preventing and relieving the symptoms of virus-induced respiratory infections. J Manipulative Physiol Ther 22 (1999) 530-533
12. Cowan D.W., Diehl S.H., and Baker A.B. Vitamins for the prevention of colds. JAMA 120 (1942) 1268-1271
13. Dahlberg G., Engel A., and Rydin H. The value of ascorbic acid as a prophylactic against common colds. Acta Med Scand 119 (1944) 540-561
14. Franz W.L., Heyl H.L., and Sands G.W. Blood ascorbic acid level in bioflavonoid and ascorbic acid therapy of common cold. JAMA 162 (1956) 1224-1226
15. Ritzel G. Critical evaluation of vitamin C as a prophylactic and therapeutic agent in colds. Helv Med Acta 28 (1961) 63-68
16. Anderson T.W., Reid D.B., and Beaton G.H. Vitamin C and the common cold: a double-blind trial. Can Med Assoc J 107 (1972) 503-508
17. Charleston S.S., and Clegg K.M. Ascorbic acid and the common cold. Lancet 1 (1972) 1401-1402
18. Wilson C.W., Loh H.S., and Foster F.G. Common cold symptomatology and vitamin C. Eur J Clin Pharmacol 6 (1973) 196-202
19. Anderson T.W., Suranyi G., and Beaton G.H. The effect on winter illness of large doses of vitamin C. Can Med Assoc J 111 (1974) 31-36
20. Coulehan J.L., Reisinger K.S., Rogers K.D., and Bradley D.W. Vitamin C prophylaxis in a boarding school. N Engl J Med 290 (1974) 6-10
21. Carson M., Cox H., Corbett M., and Pollitt N. Vitamin C and the common cold. J Soc Occup Med 25 (1975) 99-102
22. Karlowski T.R., Chalmers T.C., Grenkel L.D., Kapikian A.Z., Lewis T.L., and Lynch J.M. Ascorbic acid for the common cold. A prophylactic and therapeutic trial. JAMA 231 (1975) 1038-1042
23. Coulehan J.L., Eberhard S., Kapner L., Taylor F., Rogers K., and Garry P. Vitamin C and acute illness in Navajo school children. N Engl J Med 295 (1976) 973-977
24. Elwood P.C., Lee H.P., St Leger A.S., Baird M., and Howard A.N. A randomized controlled trial of vitamin C in the prevention and amelioration of the common cold. Br J Prev Soc Med 30 (1976) 193-196
25. Ludvigsson J., Hansson L.O., and Tibbling G. Vitamin C as a preventive medicine against common colds in children. Scand J Infect Dis 9 (1977) 91-98
26. Miller J.Z., Nance W.E., Norton J.A., Wolen R.L., Griffith R.S., and Rose R.J. Therapeutic effect of vitamin C. A co-twin control study. JAMA 237 (1977) 248-251
27. Carr A.B., Einstein R., Lai L.Y.C., Martin N.G., and Starmer G.A. Vitamin C and the common cold: a second MZ Cotwin control study. Acta Genet Med Gemellol (Roma) 30 (1981) 249-255
28. Cowan D.W., and Diehl H.S. Antihistaminic agents and ascorbic acid in the early treatment of the common cold. JAMA 143 (1950) 421-424
29. Audera C., Patulny R.V., Sander B.H., and Douglas R.M. Mega-dose vitamin C in treatment of the common cold: a randomised controlled trial. Med J Aust 175 (2001) 359-362
30. Roxas M., and Jurenka J. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev 12 (2007) 25-48
31. Kimbarowski J.A., and Mokrow N.J. Colored precipitation reaction of the urine according to Kimbarowski (FARK) as an index of the effect of ascorbic acid during treatment of viral influenza. Dtsch Gesundheitsw 22 (1967) 2413-2418
32. Hemilä H. Does vitamin C alleviate the symptoms of the common cold?-a review of current evidence. Scand J Infect Dis 26 (1994) 1-6
33. Douglas R.M., Chalker E.B., and Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2 (2000) CD000980
34. Douglas R.M., Hemilä H., D'Souza R., Chalker E., and Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 4 (2004) CD000980
35. Douglas R.M., Hemilä H., Chalker E., and Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 3 (2007) CD000980
36. Hickey S., and Roberts H. Misleading information on the properties of vitamin C. PLoS Med 2 (2005) e307
37. Hemilä H., and Herman Z.S. Vitamin C and the common cold: a retrospective analysis of Chalmers' review. J Am Coll Nutr 142 (1995) 116-123
38. Hemilä H. Vitamin C, the placebo effect, and the common cold: a case study of how preconceptions influence the analysis of results. J Clin Epidemiol 49 (1996) 1079-1084
39. Hemilä H. Vitamin C supplementation and common cold symptoms: problems with inaccurate reviews. Nutrition 12 (1996) 804-809
40. Jariwalla R., Roomi M.W., Gangapurkar B., Kalinovsky T., Niedzwiecki A., and Rath M. Suppression of influenza A virus nuclear antigen production and neuraminidase activity by a nutrient mixture containing ascorbic acid, green tea extract and amino acids. Biofactors 31 (2007) 1-15
41. Belin S., Kaya F., Duisit G., Giacometti S., Ciccolini J., and Fontés M. Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression. PLoS ONE 4 (2009) e4409
42. Zhu Y., Yongky A., and Yin J. Growth of an RNA virus in single cells reveals a broad fitness distribution. Virology 385 (2009) 39-46
43. Davy C., and Doorbar J. G2/M cell cycle arrest in the life cycle of viruses. Virology 368 (2007) 219-226
44. Kaul D., and Baba M.I. Genomic effect of vitamin 'C' and statins within human mononuclear cells involved in atherogenic process. Eur J Clin Nutr 59 (2005) 978-981
45. Kaul D., Gautam A., and Sikand K. Importance of LXR-α transcriptome in the modulation of innate immunity. Mol Cell Biochem 292 (2006) 53-57
46. Anand P.K., and Kaul D. Oxysterol receptor LXRa regulates SREBP gene expression in HL-60 cells exposed to differentiating agents. Curr Sci 82 (2002) 136-137
47. Wang H., Mannava S., Grachtchouk V., Zhuang D., Soengas M.S., Gudkov A.V., et al. c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene 27 (2008) 1905-1915
48. Bissell M.J., Hatie C., Farson D.A., Schwarz R.I., and Soo W.J. Ascorbic acid inhibits replication and infectivity of avian RNA tumor virus. Proc Natl Acad Sci U S A 77 (1980) 2711-2715
49. Harakeh S., Jariwalla R.J., and Pauling L. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc Natl Acad Sci U S A 87 (1990) 7245-7249
50. Furuya A., Uozaki M., Yamasaki H., Arakawa T., Arita M., and Koyama A.H. Antiviral effects of ascorbic and dehydroascorbic acids in vitro. Int J Mol Med 22 (2008) 541-545
51. Podmore I.D., Griffiths H.R., Herbert K.E., Mistry N., Mistry P., and Lunec J. Vitamin C exhibits pro-oxidant properties. Nature (Lond) 392 (1998) 559
52. Rehman A., Collis C.S., Yang M., Kelly M., Diplock A.T., Halliwell B., and Rice-Evans C. The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun 246 (1998) 293-298
53. Carr A., and Frei B. Does vitamin C act as a pro-oxidant under physiological conditions?. FASEB J 13 (1999) 1007-1024
54. Gutteridge J.M.C., Mumby S., Quinlan G.J., Chung K.F., and Evans T.W. Pro-oxidant iron is present in human pulmonary epithelial lining fluid: implications for oxidative stress in the lung. Biochem Biophys Res Commun 220 (1996) 1024-1027
55. Jöbsis R.Q., Schellekens S.L., Fakkel-Kroesbergen A., Raatgeep R.H.C., and de Jongste J.C. Hydrogen peroxide in breath condensate during a common cold. Mediat Inflamm 10 (2001) 351-354
56. Yeo S.J., Kim S.J., Kim J.H., Lee H.J., and Kook Y.H. Influenza A virus infection modulates the expression of type IV collagenase in epithelial cells. Arch Virol 144 (1999) 1361-1370
57. Takashi I., Tsuneo M., Madoka K., Takeshi M., Tomoyo M., and Susumu F. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy. Pediatr Infect Dis J 26 (2007) 542-544
58. Hernández Guerrero C.A., Vázquez Vela M.E., Herrerías Canedo T., Flores Herrera H., and Meraz Cruz N. Vitamin C decreases MMP-9 synthesis induced by hydrogen peroxide in an in vitro chorioamniotic membrane model. Ginecol Obstet Mex 74 (2006) 3-12
59. Wybieralska E., Koza M., Sroka J., Czyż J., and Madeja Z. Ascorbic acid inhibits the migration of walker 256 carcinosarcoma cells. Cell Mol Biol Lett 13 (2008) 103-111
60. Li W., Maeda N., and Beck M.A. Vitamin C deficiency increases the lung pathology of influenza virus-infected Gulo-/- mice. J Nutr 136 (2006) 2611-2616
61. Cross C.E., van der Vliet A., O'Neill C.A., Louie S., and Halliwell B. Oxidants, antioxidants, and respiratory tract lining fluid. Environ Health Perspect 102 (1994) 185-191
62. Fischer H., Schwarzer C., and Illek B. Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci U S A 101 (2004) 3691-3696
63. Cathcart R.F. Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy. Med Hypotheses 7 (1981) 1359-1376
64. Chen Q., Espey M.G., Sun A.Y., Pooput C., Kirk K.L., Krishna M.C., et al. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A 105 (2008) 11105-11109